Neuromodulation Market | Growth, Trends and Forecast (2019-2024)

Market Snapshot

Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Neurological diseases are frequent in older adults, affecting around 55% of people age 55 and older. They are associated with a high risk for adverse health outcomes, including mortality, disability, institutionalization, and hospitalization. Degenerative diseases, like dementia and Parkinson’s disease, as well as strokes and headaches, are frequently encountered neurological diseases in elderly patients. Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of the neurological diseases such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population. The proven efficacy and improving acceptance of this technology are expected to lead to the surge in the market demand during the forecast period.

Scope of the Report

Neuromodulators are a subset of neurotransmitter. Unlike neurotransmitters, the release of neuromodulators occurs in a diffuse manner. This means that an entire neural tissue may be subject to the neuromodulator’s action due to exposure. This in turn, can tune the neural circuitry of an entire brain region and not just that of an individual neuron.

By Technology

Internal Neuromodulation
	Spinal Cord Stimulation (SCS)
	Deep Brain Stimulation (DBS)
	Vagus Nerve Stimulation (VNS)
	Sacral Nerve Stimulation (SNS)
	Gastric Electrical Stimulation (GES)

External Neuromodulation (Non-Invasive)
	Transcutaneous Electrical Nerve Stimulation (TENS)
	Transcranial Magnetic Stimulation (TMS)
	Respiratory Electrical Stimulation (RES)

By Application
		Parkinson's disease
		Epilepsy
		Depression
		Dystonia
		Pain Management
		Other Applications

Geography

North America
	US
	Canada
	Mexico

Europe
	Germany
	UK
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Spinal Cord Stimulation (SCS) Holds the Largest Market Share in the Internal Neuromodulation Type

The process of numbing/reducing chronic pain by passing continuous low voltage electric current to the spinal cord is referred to as spinal cord stimulation (SCS). The SCS devices are FDA approved and are the most widely accepted neurostimulation techniques across the world. These devices are of basic three types namely, rechargeable, conventional, and radiofrequency systems. SCS is used in neurological problems, such as nerve damage, arachnoiditis, failed-back surgery syndrome, neuropathy, complex regional pain syndrome, and neuritis. Along with the associated benefits and effectiveness, SCS also has some pitfalls, such as overstimulation, intermittent stimulation, lead dispositioning, and device malfunctioning. However, the benefits of the SCS outrank the pitfalls, thus boosting the segment’s growth over the forecast period.

To understand key trends, Download Sample Report

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall neuromodulation market with the United States accounting as the major contributor to the market. The presence of major market players and huge pharmaceutical and biopharmaceutical industries, coupled with the rising investments in the country for the adoption of advanced technologies, is expected to boost the regional growth of the market over the forecast period. In addition, the rising concern about the prevalence of neurological disorder and other associated disorders is stimulating the need for the adoption of neuromodulation techniques. Asia-Pacific, on the other hand, is expected to grow with the fastest growth rate over the forecast period.

To understand geography trends, Download Sample Report

Competitive Landscape

The major market players in the market include Medtronic PLC, Boston Scientific Corporation, St. Jude Medical Inc., Synapse Biomedical Inc., and Nevro Corporation, among others. The increasing innovation and rise in investment for various public and private organizations are expected to intensify the industry rivalry across the world.

Major Players

* Complete list of players covered available in the table of contents below

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Rising Prevalence of Neurological Disorders
  2. 4.2.2 Increase in the Aging Population
  3. 4.2.3 Strong Product Pipeline
  4. 4.2.4 Expanded Target Applications and New Indications
  5. 4.2.5 Growing Investments
3. 4.3 Market Restraints
  1. 4.3.1 Inconsistent Reimbursement Policies
  2. 4.3.2 Lack of Trained Professionals
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Technology
  1. 5.1.1 Internal Neuromodulation
    1. 5.1.1.1 Spinal Cord Stimulation (SCS)
    2. 5.1.1.2 Deep Brain Stimulation (DBS)
    3. 5.1.1.3 Vagus Nerve Stimulation (VNS)
    4. 5.1.1.4 Sacral Nerve Stimulation (SNS)
    5. 5.1.1.5 Gastric Electrical Stimulation (GES)
  2. 5.1.2 External Neuromodulation (Non-Invasive)
    1. 5.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
    2. 5.1.2.2 Transcranial Magnetic Stimulation (TMS)
    3. 5.1.2.3 Respiratory Electrical Stimulation (RES)
2. 5.2 By Application
  1. 5.2.1 Parkinson's disease
  2. 5.2.2 Epilepsy
  3. 5.2.3 Depression
  4. 5.2.4 Dystonia
  5. 5.2.5 Pain Management
  6. 5.2.6 Other Applications
3. 5.3 Geography
  1. 5.3.1 North America
    1. 5.3.1.1 US
    2. 5.3.1.2 Canada
    3. 5.3.1.3 Mexico
  2. 5.3.2 Europe
    1. 5.3.2.1 Germany
    2. 5.3.2.2 UK
    3. 5.3.2.3 France
    4. 5.3.2.4 Italy
    5. 5.3.2.5 Spain
    6. 5.3.2.6 Rest of Europe
  3. 5.3.3 Asia-Pacific
    1. 5.3.3.1 China
    2. 5.3.3.2 Japan
    3. 5.3.3.3 India
    4. 5.3.3.4 Australia
    5. 5.3.3.5 South Korea
    6. 5.3.3.6 Rest of Asia-Pacific
  4. 5.3.4 Middle East & Africa
    1. 5.3.4.1 GCC
    2. 5.3.4.2 South Africa
    3. 5.3.4.3 Rest of Middle East & Africa
  5. 5.3.5 South America
    1. 5.3.5.1 Brazil
    2. 5.3.5.2 Argentina
    3. 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Medtronic PLC
  2. 6.1.2 Boston Scientific Corporation
  3. 6.1.3 St. Jude Medical Inc.
  4. 6.1.4 Synapse Biomedical Inc.
  5. 6.1.5 Nevro Corporation
  6. 6.1.6 Neurosigma Inc.
  7. 6.1.7 Neuropace Inc.
  8. 6.1.8 Neuronetics Inc.
  9. 6.1.9 Cyberonics Inc.
  10. 6.1.10 BioControl Medical
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments